Pattern (Discovery Tools) Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$44.2M
- Investors
-
8
Pattern (Discovery Tools) General Information
Description
Provider of single-cell microbiology antimicrobial treatment intended to simplify antibiotic selection for life-threatening infections. The company includes antibiotic selection through a lab test that uses single-cell analysis technology to shorten test time by zooming in and measuring the live response of each pathogenic cell directly, enabling doctors to improve patient outcomes and slow down the emergence of bacteria that are resistant to existing antibiotics.
Contact Information
Website
www.pattern.bioCorporate Office
- 9600 Great Hills Trail
- Suite 160E
- Austin, TX 78759
- United States
Corporate Office
- 9600 Great Hills Trail
- Suite 160E
- Austin, TX 78759
- United States
Pattern (Discovery Tools) Timeline
Pattern (Discovery Tools) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series D) | 18-Aug-2025 | $44.2M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series C) | 12-Jan-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B1) | 14-Jul-2020 | Completed | Generating Revenue | |||
| 3. Grant | 04-Feb-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 21-Oct-2019 | $6.42M | $10.2M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A1) | 02-Apr-2018 | $3.75M | $3.75M | Completed | Generating Revenue |
Pattern (Discovery Tools) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C1 | ||||||||
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | ||||||||
| Series A-1 | 4,475,239 | $0.001000 | $0.9 | $0.9 | 1x | $0.9 | 16.28% | |
| Series A | 6,000,000 | $0.001000 | $0.07 | $0.07 | 1x | $0.07 | 21.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Pattern (Discovery Tools) Comparisons
Industry
Financing
Details
Pattern (Discovery Tools) Competitors (9)
One of Pattern (Discovery Tools)’s 9 competitors is CIS Bio International, a Formerly PE-Backed company based in Saclay, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CIS Bio International | Formerly PE-Backed | Saclay, France | ||||
| Meso Scale Diagnostics | Corporation | Rockville, MD | ||||
| Akonni Biosystems | Venture Capital-Backed | Frederick, MD | ||||
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| Autogenomics | Formerly VC-backed | Carlsbad, CA |
Pattern (Discovery Tools) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pattern (Discovery Tools) Patents
Pattern (Discovery Tools) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260275400-A1 | Method for characterizing cells | Pending | 17-Mar-2025 | ||
| EP-4429816-A1 | Systems and methods for loading reagent-containing microfluidic chips having single-use valves | Pending | 10-Nov-2021 | ||
| US-20230243859-A1 | Systems and methods for loading reagent-containing microfluidic chips having single-use valves | Pending | 10-Nov-2021 | ||
| WO-2023084454-A1 | Systems and methods for loading reagent-containing microfluidic chips having single-use valves | Inactive | 10-Nov-2021 | ||
| EP-4413354-A1 | Methods for preventing inter-droplet transfer of a fluorescent product in aqueous droplets by forming a soluble complex with cyclodextrin | Pending | 06-Oct-2021 | C12N11/04 |
Pattern (Discovery Tools) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pattern (Discovery Tools) Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AMR Action Fund | Impact Investing | Minority | ||
| CoInvest Capital | Corporate Venture Capital | Minority | ||
| Daleshaw | Other | Minority | ||
| Illumina Ventures | Venture Capital | Minority | ||
| CARB-X | University |
Pattern (Discovery Tools) FAQs
-
When was Pattern (Discovery Tools) founded?
Pattern (Discovery Tools) was founded in 2016.
-
Where is Pattern (Discovery Tools) headquartered?
Pattern (Discovery Tools) is headquartered in Austin, TX.
-
What is the size of Pattern (Discovery Tools)?
Pattern (Discovery Tools) has 45 total employees.
-
What industry is Pattern (Discovery Tools) in?
Pattern (Discovery Tools)’s primary industry is Discovery Tools (Healthcare).
-
Is Pattern (Discovery Tools) a private or public company?
Pattern (Discovery Tools) is a Private company.
-
What is the current valuation of Pattern (Discovery Tools)?
The current valuation of Pattern (Discovery Tools) is .
-
What is Pattern (Discovery Tools)’s current revenue?
The current revenue for Pattern (Discovery Tools) is .
-
How much funding has Pattern (Discovery Tools) raised over time?
Pattern (Discovery Tools) has raised $92.1M.
-
Who are Pattern (Discovery Tools)’s investors?
AMR Action Fund, CoInvest Capital, Daleshaw, Illumina Ventures, and CARB-X are 5 of 8 investors who have invested in Pattern (Discovery Tools).
-
Who are Pattern (Discovery Tools)’s competitors?
CIS Bio International, Meso Scale Diagnostics, Akonni Biosystems, Ambry Genetics, and Autogenomics are some of the 9 competitors of Pattern (Discovery Tools).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
